SCHEMBL14358652

SCHEMBL14358652

COc1ccc2c(n1)c(CCC13CCC(NCc4ccc5c(n4)OC(=O)CN5)(CC1)CO3)cc(=O)n2C

nearest known ligand 0.51

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 20/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14361487 0.81 KCNH2 (0.77) KCNH2
SCHEMBL14358762 0.81 KCNH2 (0.69) KCNH2
SCHEMBL14358295 0.79 KCNH2 (0.47) KCNH2
SCHEMBL14358649 0.78 KCNH2 (0.48) KCNH2
SCHEMBL14358034 0.77 KCNH2 (0.45) KCNH2
SCHEMBL14358523 0.77 KCNH2 (0.55) KCNH2
SCHEMBL14361429 0.75 KCNH2 (0.42) KCNH2
SCHEMBL14358489 0.74 KCNH2 (0.49) KCNH2
SCHEMBL14358352 0.74 KCNH2 (0.70) KCNH2
SCHEMBL14358359 0.72 KCNH2 (0.52) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723737-A1 BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS Kyorin Pharmaceutical Co., Ltd. (JP) 2014-04-30 EP disclosed
WO-2013003383-A1 BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2013-01-03 WO disclosed